![Gunnar Olof Olsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 272 $ in data 31/08/2026
Dr. Gunnar Olof Olsson is an Independent Director at Cereno Scientific AB, a Chairman at Betagenon Sweden AB, a Chairman at Betagenon Bio AB and a Principal at Olsson Solutions Kommanditbolag.
He is on the Board of Directors at Cereno Scientific AB, IRLAB Therapeutics AB, Amplifier TX AB, BioCrine AB, Gesynta Pharma AB, Olsson Solutions AB, Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt and University of Lund.
Dr. Olsson was previously employed as a Manager-Global Cardiovascular by AstraZeneca AB and a Chairman by Athera Biotechnologies AB. He also served on the board at The European Society of Cardiology.
He received his undergraduate degree from the International Institute for Management Development and a doctorate degree from Karolinska Institutet.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 5.000 ( 0% ) | 2 272 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CERENO SCIENTIFIC AB | Direttore/Membro del Consiglio | 01/01/2024 |
| IRLAB THERAPEUTICS AB | Direttore/Membro del Consiglio | 20/02/2023 |
BioCrine AB | Direttore/Membro del Consiglio | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Direttore/Membro del Consiglio | - |
Olsson Solutions AB | Direttore/Membro del Consiglio | - |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Operates as a heart and lung foundation | Direttore/Membro del Consiglio | - |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases | Presidente | 27/05/2021 |
Betagenon Bio AB | Presidente | - |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ░░░ ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCrine AB | |
The European Society of Cardiology | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Operates as a heart and lung foundation | Commercial Services |
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases | Health Technology |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
IRLAB Therapeutics AB
 IRLAB Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for neurological diseases | Health Technology |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Health Technology |
Olsson Solutions AB | |
Betagenon Bio AB | |
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
